These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26153762)

  • 1. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
    Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
    Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.
    Roy B; Neumann RS; Snir O; Iversen R; Sandve GK; Lundin KEA; Sollid LM
    J Immunol; 2017 Jul; 199(2):782-791. PubMed ID: 28600290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
    Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
    J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
    Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
    J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
    Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
    Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
    Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
    Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
    Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing.
    Snir O; Mesin L; Gidoni M; Lundin KE; Yaari G; Sollid LM
    J Immunol; 2015 Jun; 194(12):5703-12. PubMed ID: 25972486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
    Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
    Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.